Synthesis and Characterization of Polyvinylpyrrolidone-Modified ZnO Quantum Dots and Their In Vitro Photodynamic Tumor Suppressive Action

Int J Mol Sci. 2021 Jul 28;22(15):8106. doi: 10.3390/ijms22158106.

Abstract

Despite the numerous available treatments for cancer, many patients succumb to side effects and reoccurrence. Zinc oxide (ZnO) quantum dots (QDs) are inexpensive inorganic nanomaterials with potential applications in photodynamic therapy. To verify the photoluminescence of ZnO QDs and determine their inhibitory effect on tumors, we synthesized and characterized ZnO QDs modified with polyvinylpyrrolidone. The photoluminescent properties and reactive oxygen species levels of these ZnO/PVP QDs were also measured. Finally, in vitro and in vivo experiments were performed to test their photodynamic therapeutic effects in SW480 cancer cells and female nude mice. Our results indicate that the ZnO QDs had good photoluminescence and exerted an obvious inhibitory effect on SW480 tumor cells. These findings illustrate the potential applications of ZnO QDs in the fields of photoluminescence and photodynamic therapy.

Keywords: SW480 cancer cell; nanoparticle; photodynamic therapy; photosensitizers; polyvinylpyrrolidone; quantum dot; reactive oxygen species; zinc oxide.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Female
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasms / drug therapy*
  • Photochemotherapy / methods*
  • Photosensitizing Agents* / chemical synthesis
  • Photosensitizing Agents* / pharmacology
  • Povidone* / chemistry
  • Povidone* / pharmacology
  • Quantum Dots / therapeutic use*
  • Reactive Oxygen Species / metabolism
  • Zinc Oxide* / chemistry
  • Zinc Oxide* / pharmacology

Substances

  • Antineoplastic Agents
  • Photosensitizing Agents
  • Reactive Oxygen Species
  • Povidone
  • Zinc Oxide